There has been a major breakthrough in cancer treatment recently. A new type of gene therapy, known as CAR-T cell therapy, has been introduced into clinical practice. The first of these therapies were approved in 2017 for the treatment of B-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, and primary mediastinal large B-cell lymphoma. Since then, a number of new CAR-T therapies have been introduced to the global market, all targeting hematological malignancies. However, current research shows that the…
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
